Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Hafner

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Cancer Chemotherapy and Pharmacology|February 2, 2024
UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant ExposureVikram Malhi, Malgorzata Nowicka, Ya-Chi Chen, et al.
BMC Bioinformatics|May 18, 2022
Evaluation of statistical approaches for association testing in noisy drug screening dataPetr Smirnov, Ian Smith, Zhaleh Safikhani, et al.
Nature Cancer|July 5, 2021
Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patientsJianzhu Ma, Samson H Fong, Yunan Luo, et al.
Cell Chemical Biology|June 11, 2019
Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical ActivityMarc Hafner, Caitlin E Mills, Kartik Subramanian, et al.
Nature Communications|November 14, 2022
Multiplexed and reproducible high content screening of live and fixed cells using Dye DropCaitlin E Mills, Kartik Subramanian, Marc Hafner, et al.
Nature Communications|November 1, 2017
Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profilingMario Niepel, Marc Hafner, Qiaonan Duan, et al.
Cancer Research|November 20, 2016
Systems Approaches to Cancer BiologyTenley C Archer, Elana J Fertig, Sara J C Gosline, et al.
The Journal of Biological Chemistry|November 21, 2022
Systematic pharmacological analysis of agonistic and antagonistic fibroblast growth factor receptor 1 MAbs reveals a similar unique mode of actionJocelyn Chan, Joyce Chan, Lily Shao, et al.
Journal of the American Society of Nephrology : JASN|August 12, 2015
A Quantitative Approach to Screen for Nephrotoxic Compounds In VitroMelanie Adler, Susanne Ramm, Marc Hafner, et al.
Nucleic Acids Research|June 8, 2014
LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signaturesQiaonan Duan, Corey Flynn, Mario Niepel, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|February 2, 2024
UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant ExposureVikram Malhi, Malgorzata Nowicka, Ya-Chi Chen, et al.
BMC Bioinformatics|May 18, 2022
Evaluation of statistical approaches for association testing in noisy drug screening dataPetr Smirnov, Ian Smith, Zhaleh Safikhani, et al.
Nature Cancer|July 5, 2021
Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patientsJianzhu Ma, Samson H Fong, Yunan Luo, et al.
Cell Chemical Biology|June 11, 2019
Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical ActivityMarc Hafner, Caitlin E Mills, Kartik Subramanian, et al.
Nature Communications|November 14, 2022
Multiplexed and reproducible high content screening of live and fixed cells using Dye DropCaitlin E Mills, Kartik Subramanian, Marc Hafner, et al.
Nature Communications|November 1, 2017
Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profilingMario Niepel, Marc Hafner, Qiaonan Duan, et al.
Cancer Research|November 20, 2016
Systems Approaches to Cancer BiologyTenley C Archer, Elana J Fertig, Sara J C Gosline, et al.
The Journal of Biological Chemistry|November 21, 2022
Systematic pharmacological analysis of agonistic and antagonistic fibroblast growth factor receptor 1 MAbs reveals a similar unique mode of actionJocelyn Chan, Joyce Chan, Lily Shao, et al.
Journal of the American Society of Nephrology : JASN|August 12, 2015
A Quantitative Approach to Screen for Nephrotoxic Compounds In VitroMelanie Adler, Susanne Ramm, Marc Hafner, et al.
Nucleic Acids Research|June 8, 2014
LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signaturesQiaonan Duan, Corey Flynn, Mario Niepel, et al.
Pageof 6